DSpace Repository

Compression therapy for HIV-associated Kaposi Sarcoma leg lymphedema: results of the Kenyan improvised compression for Kaposi Sarcoma randomized controlled trial

Show simple item record

dc.contributor.author Chang, Aileen Y.
dc.contributor.author Karwa, Rakhi
dc.contributor.author Odhiambo, Haji
dc.contributor.author Were, Phelix
dc.contributor.author Fletcher, Sara L.
dc.contributor.author Tonui, Edith C.
dc.contributor.author Kohn, Michael A.
dc.contributor.author Lee, Jeannette
dc.contributor.author Chang, Di
dc.contributor.author Lensing, Shelly
dc.contributor.author Namaemba, Diana Flora
dc.contributor.author Busakhala, Naftali
dc.contributor.author Kiprono, Samson K.
dc.contributor.author Maurer, Toby
dc.contributor.author Goodrich, suzanne
dc.contributor.author Pastakia, Sonak D.
dc.date.accessioned 2022-02-02T09:22:34Z
dc.date.available 2022-02-02T09:22:34Z
dc.date.issued 2022-02-02
dc.identifier.uri DOI https://doi.org/10.1200/GO.21.00329.
dc.identifier.uri http://ir.mu.ac.ke:8080/jspui/handle/123456789/5914
dc.description.abstract bstract PURPOSE Evaluate the effectiveness of compression while receiving chemotherapy compared with chemo therapy alone in the treatment of HIV-associated Kaposi sarcoma (KS) lymphedema. METHODS A randomized controlled trial was conducted in a single oncology clinic in western Kenya (NCT03404297). A computer-generated randomization schedule was used to allocate treatment arms. Randomized block design was used for stratification by lymphedema stage. Participants were HIV positive adults age ≥ 18 years on antiretroviral therapy with biopsy-proven KS associated with leg lymphedema and being initiated on chemotherapy. The intervention was 10 weeks of weekly clinic-based application of two-component paste compression bandages. The primary outcome was change in the Lower Extremity Lymphedema Index (LELI) score from week 0 to week 14. The secondary outcomes were change in the Lymphedema Quality of Life measure (LYMQOL) and change in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 score from week 0 to week 14. Blinded outcome assessments were conducted. RESULTS Of 30 participants randomly assigned, 25 eligible patients (chemotherapy [control], n = 13; com pression plus chemotherapy [intervention], n = 12) returned at week 14. Change in LELI, LYMQOL, and EORTC QLQ-C30 scores between week 14 and week 0 did not significantly differ by arm. The mean (standard deviation) change in LELI score was –25.9 (34.6) for the control arm compared with –13.3 (29.5) for the intervention arm, P = .340. The difference (95% CI) in the change in LELI score was –12.6 (–39.3 to 14.1). CONCLUSION Future studies evaluating a 14-week change in LELI for KS lymphedema should assume a standard deviation of approximately 30. Lessons learned from this pilot trial should inform the development of a larger, multicenter trial to evaluate the effectiveness of compression for KS lymphedema en_US
dc.description.sponsorship Toby Maurer, Sonak D. Pastakia en_US
dc.language.iso en en_US
dc.publisher American society of clinical oncology en_US
dc.subject Kaposi Sarcoma Leg Lymphedema en_US
dc.subject HIV en_US
dc.subject Chemotherapy en_US
dc.title Compression therapy for HIV-associated Kaposi Sarcoma leg lymphedema: results of the Kenyan improvised compression for Kaposi Sarcoma randomized controlled trial en_US
dc.title.alternative Rakhi Karwa en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account